Mats Eriksson
Department of Anaesthesiology and Intensive Care
University Hospital
Uppsala
Sweden
Name/email consistency: high
- Pharmaceutical thrombosis prevention in cardiovascular disease. Eriksson, M., Christensen, K., Lindahl, T.L., Larsson, A. Expert. Opin. Investig. Drugs (2002)
- Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock. Eriksson, M., Basu, S., Larsson, A., Mattsson, C., Eriksson, O., Kiiski, R., Nordgren, A. Expert. Opin. Investig. Drugs (2000)
- Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pig. Eriksson, M., Larsson, A., Saldeen, T., Mattsson, C. Thromb. Haemost. (1998)